LENSAR Net Income 2011-2026 | LNSR

Net profit is a financial indicator that reflects the remaining amount of money after deducting all expenses and taxes from the company’s total income over a certain period of time. It is one of the key indicators of a company’s financial stability and success.

Net profit is the portion of total profit remaining after taxes and depreciation have been deducted.^[1]

It is the result of a company’s operations and reflects its efficiency in managing resources, controlling expenses, and generating income. It includes all operating revenues and expenses, such as sales of goods or services, production costs, administrative expenses, taxes, and other financial metrics.

The calculation of net profit includes the deduction of all necessary expenses such as employee salaries, rent, utilities, taxes, and other mandatory payments. After all these expenses are deducted from the total income, the remaining amount is considered the company’s net profit.

Net profit is an important indicator of a company’s financial health, as it reflects its ability to generate earnings and manage its finances. High net profit indicates business success, competitiveness, and efficiency in resource utilization. It also allows a company to invest in its development, pay dividends to shareholders, or create reserve funds for unforeseen situations.

It serves as a basis for calculating other financial indicators, such as return on sales, return on assets, or return on equity. It is also used to assess the performance of management and make decisions regarding the future development of the company.

However, it should be noted that net profit can be affected by various factors, such as economic conditions, changes in legislation, market competition, and other external influences. Therefore, companies must be prepared for possible changes and take measures to ensure the stability of their financial results.

Annual Net Income LENSAR

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-34.3 M	-31.4 M	-14.4 M	-19.9 M	-19.6 M	-19.8 M	-14.7 M	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
-14.4 M	-34.3 M	-22 M

Quarterly Net Income LENSAR

2026-Q1	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
36.3 M	-3.71 M	-1.76 M	-27.3 M	-	-1.5 M	-9.04 M	-2.16 M	-	2.57 M	-8.75 M	-4.27 M	-	-3.99 M	-6.76 M	-6.67 M	-	-6.16 M	-4.36 M	-5.18 M	-	-4.76 M	-4.5 M	-3.69 M	-	-5.82 M	-3.79 M	-2.58 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
36.3 M	-27.3 M	-3.54 M

References

Bhamornsiri, S., & Wiggins, C. (2001). Comprehensive income disclosures. The CPA Journal, 71(10), 54.

Net Income of other stocks in the Medical devices industry

Issuer	Net Income	Price	% 24h	Market Cap	Country
GenMark Diagnostics, Inc. GNMK	-18.6 M	-	-	$ 1.77 B	USA
Avinger AVGR	-18.3 M	-	-20.74 %	$ 369 K	USA
Axonics Modulation Technologies AXNX	-6.09 M	-	-	$ 3.31 B	USA
Allied Healthcare Products AHPI	-1.94 M	-	3.58 %	$ 2.21 M	USA
Obalon Therapeutics, Inc. OBLN	-12.3 M	-	-5.86 %	$ 30.6 M	USA
ClearPoint Neuro CLPT	-25.5 M	$ 11.2	0.27 %	$ 317 M	USA
Apollo Endosurgery APEN	-39.8 M	-	-	$ 475 M	USA
Alphatec Holdings ATEC	-143 M	$ 8.24	0.24 %	$ 1.24 B	USA
Aziyo Biologics AZYO	53.4 M	-	1.37 %	$ 20.5 M	USA
EDAP TMS S.A. EDAP	-19 M	$ 4.25	-1.62 %	$ 159 M	France
BioSig Technologies BSGM	-463 M	-	37.08 %	$ 85.7 M	USA
BIOLASE BIOL	-20.6 M	-	-13.19 %	$ 166 K	USA
Conformis CFMS	-50.5 M	-	-	$ 16.4 M	USA
Cardiovascular Systems CSII	-36.9 M	-	0.15 %	$ 844 M	USA
Helius Medical Technologies HSDT	-40.9 M	$ 2.31	6.94 %	$ 50.9 M	USA
CryoLife, Inc. CRY	-16.7 M	-	-4.14 %	$ 702 M	USA
Cytosorbents Corporation CTSO	-8.2 M	$ 0.47	-0.57 %	$ 29.2 M	USA
MiMedx Group MDXG	48.6 M	$ 3.79	4.12 %	$ 560 M	USA
OrthoPediatrics Corp. KIDS	-39.6 M	$ 18.5	1.48 %	$ 434 M	USA
LivaNova PLC LIVN	-242 M	$ 73.71	1.08 %	$ 4.02 B	Britain
Delcath Systems DCTH	2.7 M	$ 11.23	3.5 %	$ 402 M	USA
Soliton, Inc. SOLY	-14.5 M	-	-1.42 %	$ 435 M	USA
Hancock Jaffe Laboratories, Inc. HJLI	-9.14 K	-	-1.98 %	$ 98.3 M	USA
Itamar Medical Ltd. ITMR	-10.9 M	-	0.03 %	$ 1.58 B	Israel
Misonix, Inc. MSON	-17.4 M	-	-	$ 462 M	USA
Neovasc NVCN	-24.9 M	-	-	$ 111 M	Canada
IRIDEX Corporation IRIX	-4.44 M	$ 1.0	-4.76 %	$ 16.9 M	USA
Dynatronics Corporation DYNT	-10.9 M	-	14.99 %	$ 929 K	USA
Eargo EAR	-157 M	-	-	$ 10.2 M	USA
Pulmonx Corporation LUNG	-54 M	$ 1.54	14.93 %	$ 62.7 M	USA
Electromed ELMD	7.54 M	$ 37.74	-1.64 %	$ 319 M	USA
Myomo MYO	-15.6 M	$ 0.91	4.17 %	$ 38.1 M	USA
Butterfly Network BFLY	-77.1 M	$ 4.39	6.94 %	$ 1.08 B	USA
Intersect ENT, Inc. XENT	-72.3 M	-	-	$ 955 M	USA
Second Sight Medical Products EYES	26.6 M	-	-0.97 %	$ 54.4 M	USA
Orthofix Medical OFIX	-92.2 M	$ 12.15	0.5 %	$ 481 M	Curacao
Sintx Technologies SINT	-10.4 M	$ 2.21	0.45 %	$ 6.13 M	USA
GBS GBS	-10.6 M	-	-0.57 %	$ 7.12 M	USA
Profound Medical Corp. PROF	-42.6 M	$ 6.92	2.82 %	$ 209 M	Canada
Globus Medical GMED	538 M	$ 84.03	5.13 %	$ 11.4 B	USA
Insulet Corporation PODD	247 M	$ 156.59	1.28 %	$ 11 B	USA
CONMED Corporation CNMD	47.1 M	$ 37.01	2.29 %	$ 1.15 B	USA
Inspire Medical Systems INSP	145 M	$ 44.14	3.79 %	$ 1.3 B	USA
TransMedics Group TMDX	190 M	$ 68.0	2.83 %	$ 2.31 B	USA
Integer Holdings Corporation ITGR	103 M	$ 91.49	1.16 %	$ 3.18 B	USA
Invacare Corporation IVC	-20.6 M	-	-	$ 24.7 M	USA
Edwards Lifesciences Corporation EW	1.07 B	$ 82.97	0.99 %	$ 48.5 B	USA